{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:14:59Z","timestamp":1772165699793,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-025-04482-9","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T10:36:11Z","timestamp":1763980571000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Non-traditional barriers to participation in pharmacologic chronic kidney disease clinical trials"],"prefix":"10.1186","volume":"26","author":[{"given":"Gabriel","family":"Cojuc-Konigsberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Braverman-Poyastro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vianca Anabel","family":"Canaviri-Flores","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandra","family":"De Las Fuentes Cepeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Briana","family":"Rodriguez-Paniagua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Mizrahi-Drijanski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Guijosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Nordmann-Gomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Moscona-Nissan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Correa-Rotter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan C.","family":"Ram\u00edrez-Sandoval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"key":"4482_CR1","unstructured":"United Nations. Transforming our world: The 2030 agenda for sustainable development. https:\/\/sustainabledevelopment.un.org\/content\/documents\/21252030%20Agenda%20for%20Sustainable%20Development%20web.pdf. October 15, 2015. Accessed December 20, 2024"},{"key":"4482_CR2","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","volume":"395","author":"GBD Chronic Kidney Disease Collaboration","year":"2020","unstructured":"GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017. A systematic analysis for the global burden of disease study 2017. Lancet. 2020;395:709\u201333.","journal-title":"Lancet"},{"key":"4482_CR3","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1016\/S0140-6736(18)31694-5","volume":"392","author":"KJ Foreman","year":"2018","unstructured":"Foreman KJ, Marquez N, Dolgert A, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: Reference and alternative scenarios for 2016\u201340 for 195 countries and territories. Lancet. 2018;392:2052\u201390.","journal-title":"Lancet"},{"key":"4482_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41581-020-00363-6","volume":"17","author":"VA Luyckx","year":"2021","unstructured":"Luyckx VA, Al-Aly Z, Bello AK, et al. Sustainable development goals relevant to kidney health: An update on progress. Nat Rev Nephrol. 2021;17:15\u201332.","journal-title":"Nat Rev Nephrol"},{"key":"4482_CR5","doi-asserted-by":"publisher","first-page":"e382","DOI":"10.1016\/S2214-109X(23)00570-3","volume":"12","author":"AK Bello","year":"2024","unstructured":"Bello AK, Okpechi IG, Levin A, et al. An update on the global disparities in kidney disease burden and care across world countries and regions. Lancet Glob Health. 2024;12:e382\u201395.","journal-title":"Lancet Glob Health"},{"key":"4482_CR6","unstructured":"Bello AK, Okpechi IG, Levin A, et al. ISN-Global kidney health atlas: A report by the International society of nephrology: An assessment of global kidney health Care status focusing on capacity, availability, accessibility, affordability and outcomes of kidney disease. 2023. Brussels. Belgium: International Society of Nephrology."},{"key":"4482_CR7","doi-asserted-by":"crossref","unstructured":"Perkovic V, Craig JC, Chailimpamontree W, et al. Action plan for optimizing the design of clinical trials in chronic kidney disease. Kidney Int Suppl. (2011). 2017;7:138\u2013144.","DOI":"10.1016\/j.kisu.2017.07.009"},{"issue":"8","key":"4482_CR8","first-page":"82","volume":"2018","author":"IG Okpechi","year":"2011","unstructured":"Okpechi IG, Alrukhaimi M, Ashuntantang GE, et al. Global capacity for clinical research in nephrology: A survey by the International society of Nephrology. Kidney Int Suppl. (2011). 2018;(8):82\u201389.","journal-title":"Kidney Int Suppl"},{"issue":"1","key":"4482_CR9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1053\/j.ajkd.2024.06.012","volume":"85","author":"G Cojuc-Konigsberg","year":"2025","unstructured":"Cojuc-Konigsberg G, Guijosa A, Moscona-Nissan A, et al. Representation of low- and middle-income countries in CKD drug trials: A systematic review. Am J Kidney Dis. 2025;85(1):55\u201366.e1. https:\/\/doi.org\/10.1053\/j.ajkd.2024.06.012.","journal-title":"Am J Kidney Dis"},{"key":"4482_CR10","unstructured":"National Institutes of Health- Office of Research on Women\u2019s Health. Primary barriers and facilitators to participation in clinical research. https:\/\/orwh.od.nih.gov\/sites\/orwh\/files\/docs\/orwh_outreach_toolkit_litreview.pdf. Accessed March 15, 2024"},{"key":"4482_CR11","doi-asserted-by":"publisher","first-page":"100829","DOI":"10.1016\/j.conctc.2021.100829","volume":"23","author":"E Rodr\u00edguez-Torres","year":"2021","unstructured":"Rodr\u00edguez-Torres E, Gonz\u00e1lez-P\u00e9rez MM, D\u00edaz-P\u00e9rez C. Barriers and facilitators to the participation of subjects in clinical trials: An overview of reviews. Contemp Clin Trials Commun. 2021;23:100829.","journal-title":"Contemp Clin Trials Commun"},{"key":"4482_CR12","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.amjms.2023.07.011","volume":"366","author":"LS Craig","year":"2023","unstructured":"Craig LS, Sarpong DF, Peacock EM, et al. Clinical trial participation among underserved communities: Insights from the Louisiana Community Engagement Alliance. Am J Med Sci. 2023;366:254\u201362.","journal-title":"Am J Med Sci"},{"key":"4482_CR13","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1093\/ndt\/gfac302","volume":"38","author":"GL Hundemer","year":"2023","unstructured":"Hundemer GL, Ravani P, Sood MM, et al. Social determinants of health and the transition from advanced chronic kidney disease to kidney failure. Nephrol Dial transplant. 2023;38:1682\u201390.","journal-title":"Nephrol Dial transplant"},{"key":"4482_CR14","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.semnephrol.2019.02.003","volume":"39","author":"DC Crews","year":"2019","unstructured":"Crews DC, Novick TK. Social determinants of CKD hotspots. Semin Nephrol. 2019;39:256\u201362.","journal-title":"Semin Nephrol"},{"key":"4482_CR15","doi-asserted-by":"publisher","first-page":"414","DOI":"10.2471\/BLT.17.206441","volume":"96","author":"VA Luyckx","year":"2018","unstructured":"Luyckx VA, Tonelli M, Stanifer JW. The global burden of kidney disease and the sustainable development goals. Bull World Health Organ. 2018;96:414\u201322D.","journal-title":"Bull World Health Organ"},{"key":"4482_CR16","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s12882-017-0685-4","volume":"18","author":"R Jagannathan","year":"2017","unstructured":"Jagannathan R, Patzer RE. Urbanization and kidney function decline in low and middle income countries. BMC Nephrol. 2017;18:276.","journal-title":"BMC Nephrol"},{"key":"4482_CR17","doi-asserted-by":"crossref","unstructured":"Luyckx VA, Tuttle KR, Garcia-Garcia G, et al. Reducing major risk factors for chronic kidney disease. Kidney Int Suppl. (2011). 2017;7:71\u201387.","DOI":"10.1016\/j.kisu.2017.07.003"},{"key":"4482_CR18","unstructured":"World Health Organization. Indicators. The global health observatory data repository. https:\/\/www.who.int\/data\/gho\/data\/indicatorsAccessed February 2, 2024"},{"key":"4482_CR19","doi-asserted-by":"crossref","unstructured":"Tonelli M, Nkunu V, Varghese C, et al. Framework for establishing integrated kidney care programs in low- and middle-income countries. Kidney Int Suppl. (2011). 2020;10:e19\u201323.","DOI":"10.1016\/j.kisu.2019.11.002"},{"key":"4482_CR20","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.kint.2023.12.003","volume":"105","author":"VA Luyckx","year":"2024","unstructured":"Luyckx VA, Tuttle KR, Abdellatif D, et al. Mind the gap in kidney care: translating what we know into what we do. Kidney Int. 2024;105:406\u201317.","journal-title":"Kidney Int"},{"key":"4482_CR21","unstructured":"Higgs C, Liu S, Boeing G, et al. Global healthy and sustainable city indicator study collaboration - 25 cities spatial indicators datasets. 2023 July 25. https:\/\/rmit.figshare.com\/articles\/dataset\/Global_Healthy_and_Sustainable_City_Indicator_Study_Collaboration_-_25_Cities_spatial_indicators_datasets\/15072009. Accessed February 2, 2024"},{"key":"4482_CR22","doi-asserted-by":"publisher","first-page":"e907","DOI":"10.1016\/S2214-109X(22)00072-9","volume":"10","author":"G Boeing","year":"2022","unstructured":"Boeing G, Higgs C, Liu S, et al. Using open data and open-source software to develop spatial indicators of urban design and transport features for achieving healthy and sustainable cities. Lancet Glob Health. 2022;10:e907\u201318.","journal-title":"Lancet Glob Health"},{"key":"4482_CR23","unstructured":"The World Bank. World Bank Open Data. https:\/\/data.worldbank.org\/. Accessed February 2, 2024"},{"key":"4482_CR24","unstructured":"The World Bank. World bank country and lending groups - world bank data help desk. https:\/\/datahelpdesk.worldbank.org\/knowledgebase\/articles\/906519. Accessed February 2, 2024"},{"key":"4482_CR25","volume-title":"Global burden of disease study 2019 (GBD 2019) Socio-demographic index (SDI) 1950-2019","author":"Global Burden of Disease Collaborative Network","year":"2020","unstructured":"Global Burden of Disease Collaborative Network. Global burden of disease study 2019 (GBD 2019) Socio-demographic index (SDI) 1950\u20132019. Seattle, WA: Institute for Health Metrics and Evaluation (IHME); 2020."},{"key":"4482_CR26","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1080\/07853890.2018.1453233","volume":"50","author":"A Krauss","year":"2018","unstructured":"Krauss A. Why all randomised controlled trials produce biased results. Ann Med. 2018;50:312\u201322.","journal-title":"Ann Med"},{"key":"4482_CR27","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1162\/qss_a_00268","volume":"4","author":"K Okamura","year":"2023","unstructured":"Okamura K. A half-century of global collaboration in science and the \u201cshrinking world\u201d. Quant Sci Stud. 2023;4:938\u201359.","journal-title":"Quant Sci Stud"},{"key":"4482_CR28","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/nrneph.2014.98","volume":"10","author":"A Levin","year":"2014","unstructured":"Levin A, Remuzzi G. ISN-ACCTS: Global initiatives to improve clinical research. Nat Rev Nephrol. 2014;10:426\u201327.","journal-title":"Nat Rev Nephrol"},{"key":"4482_CR29","doi-asserted-by":"publisher","first-page":"205435812110303","DOI":"10.1177\/20543581211030396","volume":"8","author":"A Murdoch","year":"2021","unstructured":"Murdoch A, Tennankore KK, Bohm C, et al. Re-envisioning the Canadian nephrology trials network: A can-SOLVE-CKD stakeholder meeting of patient partners and researchers. Can J Kidney Health Dis. 2021;8:20543581211030396.","journal-title":"Can J Kidney Health Dis"},{"key":"4482_CR30","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1093\/ckj\/sfab170","volume":"15","author":"A Ortiz","year":"2021","unstructured":"Ortiz A, Roger M, Jim\u00e9nez VM, et al. RICORS2040: The need for collaborative research in chronic kidney disease. Clin Kidney J. 2021;15:372\u201387.","journal-title":"Clin Kidney J"},{"key":"4482_CR31","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1681\/ASN.2019090869","volume":"31","author":"ML Mendu","year":"2020","unstructured":"Mendu ML, Tummalapalli SL, Lentine KL, et al. Measuring quality in kidney care: An evaluation of existing quality metrics and approach to facilitating improvements in care delivery. J Am Soc Nephrol. 2020;31:602\u201314.","journal-title":"J Am Soc Nephrol"},{"key":"4482_CR32","doi-asserted-by":"publisher","first-page":"E74","DOI":"10.9778\/cmajo.20160113","volume":"5","author":"K Tu","year":"2017","unstructured":"Tu K, Bevan L, Hunter K, Rogers J, Young J, Nesrallah G. Quality indicators for the detection and management of chronic kidney disease in primary care in Canada derived from a modified delphi panel approach. CMAJ Open. 2017;5:E74\u201381.","journal-title":"CMAJ Open"},{"key":"4482_CR33","unstructured":"US Department of Health and Human Services. Guidance for Industry. E6 good clinical practice: Consolidated guidance. International Conference on Harmonisation. 1996 April. http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM073122.pdf. Accessed March 31, 2024."},{"key":"4482_CR34","unstructured":"International Organization for Standardization. ISO 9001: 2015. Qual Manag Syst Int Organ For standardization. 2015."},{"key":"4482_CR35","volume-title":"ISO 14155: 2020. Clinical investigation of medical devices for human subjects","author":"International Organization for Standardization","year":"2020","unstructured":"International Organization for Standardization. ISO 14155: 2020. Clinical investigation of medical devices for human subjects. International Organization for Standardization; 2020."},{"key":"4482_CR36","volume-title":"ISO 37120: 2018. Sustainable cities and communities: Indicators for city services and quality of life","author":"International Organization for Standardization","year":"2018","unstructured":"International Organization for Standardization. ISO 37120: 2018. Sustainable cities and communities: Indicators for city services and quality of life. International Organization for Standardization; 2018."},{"key":"4482_CR37","doi-asserted-by":"publisher","first-page":"e000380","DOI":"10.1136\/bmjgh-2017-000380","volume":"2","author":"BL Neuen","year":"2017","unstructured":"Neuen BL, Chadban SJ, Demaio AR, Johnson DW, Perkovic V. Chronic kidney disease and the global NCDs agenda. BMJ Glob Health. 2017;2:e000380.","journal-title":"BMJ Glob Health"},{"key":"4482_CR38","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1681\/ASN.0000000000000134","volume":"34","author":"QH Soomro","year":"2023","unstructured":"Soomro QH, McCarthy A, Varela D, et al. Representation of racial and ethnic minorities in nephrology clinical trials: A systematic review and meta-analysis. J Am Soc Nephrol. 2023;34:1167\u201377.","journal-title":"J Am Soc Nephrol"},{"key":"4482_CR39","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.34067\/KID.0000000000000281","volume":"4","author":"QH Soomro","year":"2023","unstructured":"Soomro QH, McCarthy A, Charytan AM, et al. Gender disparities in nephrology trials: A meta-analysis of enrollment trends between 2000 and 2021. Kidney360. 2023;4:1545\u201353.","journal-title":"Kidney360"},{"key":"4482_CR40","doi-asserted-by":"publisher","first-page":"e001940","DOI":"10.1136\/bmjgh-2019-001940","volume":"4","author":"B Smyth","year":"2019","unstructured":"Smyth B, Trongtrakul K, Haber A, et al. Inequities in the global representation of sites participating in large, multicentre dialysis trials: a systematic review. BMJ Global Health. 2019;4:e001940.","journal-title":"BMJ Global Health"},{"key":"4482_CR41","doi-asserted-by":"crossref","unstructured":"Winkfield KM, Phillips JK, Joffe S, Halpern MT, Wollins DS, Moy B. Addressing financial barriers to patient participation in clinical trials: ASCO policy statement. J Clin Oncol. 2018: JCO1801132.","DOI":"10.1200\/JCO.18.01132"},{"key":"4482_CR42","doi-asserted-by":"crossref","unstructured":"Wong AR, Sun V, George K, et al. Barriers to participation in therapeutic clinical trials as perceived by community oncologists. JCO Oncol Pract. 2020;16.","DOI":"10.1200\/JOP.19.00662"},{"key":"4482_CR43","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1053\/j.ajkd.2007.10.047","volume":"53","author":"MP Hossain","year":"2009","unstructured":"Hossain MP, Goyder EC, Rigby JE, El Nahas M. CKD and poverty: a growing global challenge. Am J Kidney Dis. 2009;53:166\u201374.","journal-title":"Am J Kidney Dis"},{"key":"4482_CR44","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1016\/S0140-6736(16)30066-6","volume":"388","author":"B Giles-Corti","year":"2016","unstructured":"Giles-Corti B, Vernez-Moudon A, Reis R, et al. City planning and population health: a global challenge. Lancet. 2016;388:2912\u201324.","journal-title":"Lancet"},{"key":"4482_CR45","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1186\/s12889-023-15908-0","volume":"23","author":"S Danielli","year":"2023","unstructured":"Danielli S, Ashrafian H, Darzi A. Healthy city: global systematic scoping review of city initiatives to improve health with policy recommendations. BMC Public Health. 2023;23:1277.","journal-title":"BMC Public Health"},{"key":"4482_CR46","doi-asserted-by":"publisher","first-page":"e919","DOI":"10.1016\/S2214-109X(22)00066-3","volume":"10","author":"B Giles-Corti","year":"2022","unstructured":"Giles-Corti B, Moudon AV, Lowe M, et al. What next? Expanding our view of city planning and global health, and implementing and monitoring evidence-informed policy. Lancet Glob Health. 2022;10:e919\u201326.","journal-title":"Lancet Glob Health"},{"key":"4482_CR47","doi-asserted-by":"publisher","first-page":"e782","DOI":"10.1016\/S2214-109X(22)00070-5","volume":"10","author":"B Giles-Corti","year":"2022","unstructured":"Giles-Corti B, Moudon AV, Lowe M, et al. Creating healthy and sustainable cities: what gets measured, gets done. Lancet Glob Health. 2022;10:e782\u201385.","journal-title":"Lancet Glob Health"},{"key":"4482_CR48","unstructured":"World Health Organization. Integrating health in urban and territorial planning: a sourcebook. World Health Organization, 2020."},{"key":"4482_CR49","doi-asserted-by":"publisher","first-page":"k 2130","DOI":"10.1136\/bmj.k2130","volume":"361","author":"M Zwierzyna","year":"2018","unstructured":"Zwierzyna M, Davies M, Hingorani AD, Hunter J. Clinical trial design and dissemination: comprehensive analysis of clinicaltrials.gov and PubMed data since 2005. BMJ. 2018;361:k 2130.","journal-title":"BMJ"},{"issue":"9","key":"4482_CR50","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.2215\/CJN.17561120","volume":"16","author":"JH Ishida","year":"2021","unstructured":"Ishida JH, Chauhan C, Gillespie B, et al. Understanding and overcoming the challenges related to cardiovascular trials involving patients with kidney disease. Clin J Am Soc Nephrol. 2021;16(9):1435\u201344. https:\/\/doi.org\/10.2215\/CJN.17561120.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"4482_CR51","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.kint.2020.10.048","volume":"99","author":"RDR Evans","year":"2021","unstructured":"Evans RDR, Smyth B, Levin A, et al. The International society of nephrology advancing clinical trials (ISN-ACT) network: current activities and future goals. Kidney Int. 2021;99(3):551\u201354. https:\/\/doi.org\/10.1016\/j.kint.2020.10.048.","journal-title":"Kidney Int"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04482-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04482-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04482-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T18:12:27Z","timestamp":1764180747000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04482-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4482"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04482-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7013841\/v1","asserted-by":"object"}]},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,24]]},"assertion":[{"value":"30 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Juan C. Ram\u00edrez\u2014Sandoval is a member of the Review Board of Frontiers in Medicine, has received honoraria for lectures from Abbvie, Amgen, Synthom, Bayer, Fresenius, Vifor, and AstraZeneca, and has received equipment from Biogen. Ricardo Correa\u2014Rotter is a member of the Review Board of Blood Purification, has received honoraria as a consultant from AstraZeneca, Chinook, Bayer, Novo Nordisk, and Boehringer Ingelheim, participates in research from Boehringer Ingelheim, Roche, Chinook, Novo Nordisk, and AstraZeneca, has lectured for Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, and Amgen, and is a member of the World Kidney Day Steering Committee and SLANH Diabetes Committee. Gabriel Cojuc\u2014Konigsberg, Alan Braverman\u2014Poyastro, Vianca Anabel Canaviri\u2014Flores, Alejandra de las Fuentes Cepeda, Briana Rodriguez\u2014Paniagua, Andrea Mizrahi\u2014Drijanski, Alberto G\u00fcijosa, Alberto Nordmann\u2014Gomes, and Alberto Moscona\u2014Nissan declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"660"}}